Skin cancer risk in alopecia areata: a systematic review and meta-analysis
-
By
-
Simonetta I. Gaumond
-
Alireza Abdshah
-
Isabella Kamholtz
-
Peyton V. Warp
-
Keyvan Nouri
-
Antonella Tosti
-
Joaquin J. Jimenez
-
May 11, 2026
-
Clinical Scorecard: Association Between Alopecia Areata and Skin Cancer Risk: A Comprehensive Review and Meta-Analysis
At a Glance
| Category | Detail |
|---|
| Condition | |
| Key Mechanisms | Enhanced cytotoxic immune activity may paradoxically reduce skin cancer risk. |
| Target Population | |
| Care Setting | |
Key Highlights
- Overall skin cancer risk is reduced but not statistically significant (OR 0.58, 95% CI, 0.27-1.22).
Guideline-Based Recommendations
Diagnosis
Management
- Consider the implications of systemic therapies on skin cancer risk, including specific therapies like JAK inhibitors.
Monitoring & Follow-up
Risks
Patient & Prescribing Data
Long-term safety data for systemic therapies like JAK inhibitors remain limited, but emerging evidence suggests potential benefits.
Clinical Best Practices
- Counsel patients about the potential reduced risk of skin cancers associated with Alopecia Areata and educate on UV protection.
Related Resources & Content
